Merck KGaA
Merck KGaA (MKGAF) Revenue
Annual & quarterly revenue history · segment & region breakdown
MKGAF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsMerck KGaA trailing twelve-month (TTM) revenue is $20.97B, a decrease of 0.29% year-over-year from $21.09B in FY2025.
Revenue trend
2025 – 2006 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2025-12-31 | $21.09B | -$0.06B | -0.29% |
| 2024-12-31 | $21.16B | +$0.16B | +0.78% |
| 2023-12-31 | $20.99B | -$1.24B | -5.57% |
| 2022-12-31 | $22.23B | +$2.54B | +12.93% |
| 2021-12-31 | $19.69B | +$2.15B | +12.28% |
| 2020-12-31 | $17.53B | +$1.38B | +8.56% |
| 2019-12-31 | $16.15B | +$1.32B | +8.87% |
| 2018-12-31 | $14.84B | -$0.49B | -3.20% |
| 2017-12-31 | $15.33B | +$0.30B | +2.02% |
| 2016-12-31 | $15.02B | +$2.18B | +16.97% |
Compare revenue vs peers
Drug Manufacturers - Specialty & GenericCompare MKGAF revenue against listed peers. Click any row to open that company's revenue tab.
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Merck KGaA receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Merck KGaA reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in EUR.
Data sourced from Merck KGaA's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
MKGAF revenue · 4 questionsMKGAF's trailing twelve-month (TTM) revenue is $20.97B. That is a decrease of 0.29% year-over-year from $21.09B in FY2025.
▸ Source: FMP · Merck KGaA SEC filings · GAAP · Merck KGaA SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026